ERBB2 and neoplasm: Furthermore, EGFR and HER-2 have been revealed to play a significant role in metastasis to the bone marrow (Day et al. 2017; Lu and Kang 2010), and these factors exhibited elevated activity in tumour initiating cells (TICs) and circulating tumour cells (CTCs) (Day et al. 2017).